Evidence map›Paper›PMID 41915818›Full record

ArticleSexually transmitted diseases2026

The Path of Estimated Resistance: Updates of the Estimated Number and Cost of Antimicrobial-Resistant Gonococcal Infections in Men and Women Aged 15 to 39 Years in the United States: 2018-2023.

Kristen M Kreisel, Harrell W Chesson, Matthew W Schmerer, Ian H Spicknall

Abstract read
In one paragraph

Article in Sexually transmitted diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kristen M KreiselFrom the Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
Harrell W Chesson
Matthew W Schmerer
Ian H Spicknall

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Using progressively refined methodology, this study estimated the number and cost of incident antimicrobial-resistant gonococcal infections during 2018-2023. An estimated 787,000 incident antimicrobial-resistant gonococcal infections in persons aged 15 to 39 years occurred in 2023, with lifetime costs of $214.5M and 80% of costs attributable to infections in women.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialGonorrheaNeisseria gonorrhoeaeAdolescentAdultFemaleHumansIncidenceMaleUnited StatesYoung AdultAnti-Bacterial Agents

Identifiers

PMID41915818
PMCPMC13103950

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.